Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cell-to-cell contact, also known as juxtacrine or contact-dependent signaling, is a fundamental biological process where physical interaction between adjacent cells mediates signal transmission [2, 6]. This communication is facilitated by diverse molecular structures, including cell adhesion molecules like cadherins and integrins, gap junctions composed of connexins, and membrane-bound ligand-receptor pairs such as Notch-Delta and PD-1/PD-L1 [1, 3, 6]. These interactions are essential for coordinating physiological functions including embryonic development, immune system activation, and the maintenance of tissue architecture [4, 7]. In pathological states, dysregulated cell-to-cell contact plays a pivotal role in cancer metastasis through the epithelial-mesenchymal transition and immune evasion via checkpoint signaling [1, 2, 8]. Furthermore, certain pathogens, such as HIV and HTLV-1, exploit direct cell-to-cell contact via virological synapses to spread efficiently while avoiding neutralizing antibodies [9, 13]. Therapeutic strategies targeting these pathways include monoclonal antibodies that block adhesion or immune checkpoints, as well as small molecules intended to modulate gap junction permeability or disrupt cell-mediated viral dissemination [1, 2, 8, 13].
Inhibition of cell adhesion via integrin blockade, disruption of immune checkpoint interactions, modulation of gap junction permeability, and inhibition of contact-dependent viral transmission [1, 2, 8, 13].
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cell-to-cell contact.